Interestingly, in the case of HCC, for the first time in the history of clinical oncology, in 2001, in Barcelona, the EASL expert panel established the criteria for the diagnosis of malignant neoplasm solely on the basis of imaging tests and additional examination of serum AFP (alpha fetoprotein) concentration without the need for histological verification [62]. This evidence concerns the gene AFP and cancer.